No Data
Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment
Anavex Life Sciences Reveals Peer-reviewed Publication Of Oral Blarcamesine Phase IIb/III Data In Journal Of Prevention Of Alzheimer's Disease
Express News | Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase Iib/III Data in the Journal of Prevention of Alzheimer’s Disease
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease
Anavex Reports Long-Term Benefits of Blarcamesine in Slowing Early Alzheimer's Disease Progression
Express News | D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $46 Price Target
No Data
Rhiox : getting close
Rhiox : i usually load up when its in the mid 8.'s. Have done pretty good with that enrty point many times over.